Anika Therapeutics, Inc. Logo

Anika Therapeutics, Inc.

A global joint preservation company developing solutions for orthopedic care.

ANIK | US

Overview

Corporate Details

ISIN(s):
US0352551081
LEI:
Country:
United States of America
Address:
32 WIGGINS AVENUE, 1730 BEDFORD

Description

Anika Therapeutics, Inc. is a global joint preservation company focused on developing, manufacturing, and marketing solutions for early intervention orthopedic care. The company provides a range of therapeutic products and regenerative solutions designed to treat degenerative orthopedic diseases, traumatic conditions, joint pain, and arthritis. Its portfolio, which utilizes technologies such as hyaluronic acid, aims to restore joint function and enable patients to maintain an active lifestyle. Key products include the Integrity™ Implant System, a regenerative scaffold for tendon augmentation. Anika partners with medical professionals to deliver treatments across the continuum of joint care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2012-10-30 17:30
ANIKA THERAPEUTICS, INC. 8-K
English 25.0 KB
2012-08-07 18:07
ANIKA THERAPEUTICS, INC. 10-Q
English 819.1 KB
2012-08-02 16:27
ANIKA THERAPEUTICS, INC. 8K
English 25.0 KB
2012-06-14 19:28
ANIKA THERAPEUTICS, INC. 8-K
English 8.4 KB
2012-06-11 20:28
ANIKA THERAPEUTICS, INC. 8-K
English 9.9 KB
2012-05-07 18:55
ANIKA THERAPEUTICS, INC. 10-Q
English 459.2 KB
2012-05-03 19:21
ANIKA THERAPEUTICS, INC. 8-K
English 24.0 KB
2012-04-25 18:32
ANIKA THERAPEUTICS, INC. DEFA14A
English 460.9 KB
2012-04-25 18:24
ANIKA THERAPEUTICS, INC. DEF 14A
English 593.2 KB
2012-04-23 17:14
FORM 4
English 5.4 KB
2012-04-23 17:11
FORM 4
English 5.5 KB
2012-03-20 18:35
FORM 4
English 5.3 KB
2012-03-16 17:38
FORM 4
English 5.7 KB
2012-03-13 10:44
ANIKA THERAPEUTICS, INC. 10-K
English 1012.2 KB
2012-03-08 20:12
FORM 4
English 6.1 KB

Automate Your Workflow. Get a real-time feed of all Anika Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Anika Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Anika Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ATAI Life Sciences N.V. Logo
Develops psychedelic-inspired therapies for mental health disorders.
United States of America
ATAI
Atea Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing oral antiviral therapies for serious viral diseases.
United States of America
AVIR
Athira Pharma, Inc. Logo
Biopharma firm developing small molecule therapeutics for neurodegenerative diseases.
United States of America
ATHA
ATOSSA THERAPEUTICS, INC. Logo
Clinical-stage biopharmaceutical company developing oncology medicines for breast cancer.
United States of America
ATOS
aTYR PHARMA INC Logo
Develops medicines based on tRNA synthetase biology for fibrosis and inflammation.
United States of America
ATYR
Aura Biosciences, Inc. Logo
Develops Virus-Like Drug Conjugates as targeted therapies for solid tumors.
United States of America
AURA
Aurinia Pharmaceuticals Inc. Logo
Biopharmaceutical company developing therapies for severe autoimmune diseases.
United States of America
AUPH
AURORA CANNABIS INC Logo
Global producer and distributor of cannabis for medical and recreational markets.
United States of America
ACB
Autolus Therapeutics plc Logo
Biopharmaceutical company developing programmed T cell therapies for cancer and autoimmune diseases.
United States of America
AUTL
AVACTA GROUP PLC Logo
Clinical-stage biotech developing targeted oncology drugs with a proprietary platform.
United Kingdom
AVCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.